CIMG Inc. (CIMG)
OTCMKTS · Delayed Price · Currency is USD
0.0060
-0.00055 (-8.40%)
At close: Jul 30, 2026
CIMG Inc. Financials Overview
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Revenue Revenue Growth | 29.26 | 20.53 | 3.86 | 1.76 | 3.11 | 1.93 |
Revenue Growth | 4214.95% | 431.77% | 119.61% | -43.46% | 61.38% | 37.31% |
Gross Profit Gross Profit Growth | 0.21 | 0.13 | 0.03 | -0.21 | -0.11 | -0.08 |
Operating Income Operating Income Growth | -6.26 | -5.2 | -10.86 | -8.39 | -11.4 | -18 |
Net Income Net Income Growth | -37.83 | -4.88 | -8.97 | -8.75 | -11.8 | -18.55 |
Earnings Per Share EPS Growth | -2.12 | -2.80 | -83.46 | -239.00 | -426.40 | -791.00 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | FY 2025 | FY 2024 |
|---|---|---|
| Period Ending | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 |
Homology of Medicine and Food Series Homology of Medicine and Food Series Growth | 6.35 | - |
Computing Power Product Series Computing Power Product Series Growth | 3.8 | - |
Maca Product Series Maca Product Series Growth | 0.14 | 1.93 |
Adjustments and Elimination Adjustments and Elimination Growth | -0 | - |
Total Total Growth | 10.3 | 1.93 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Cash & Investments Cash & Investments Growth | 0.02 | 0.14 | 0.46 | 0.98 | 8.32 | 10.82 |
Total Debt Total Debt Growth | 1.62 | 2.3 | 3.4 | 0.41 | 0.72 | 0.53 |
Net Cash (Debt) Net Cash Growth | -1.6 | -2.16 | -2.94 | 0.57 | 7.59 | 10.28 |
Net Cash Growth | - | - | - | -92.44% | -26.17% | 191.60% |
Net Cash Per Share Net Cash Per Share Growth | -0.13 | -1.24 | -27.35 | 15.66 | 274.42 | 438.54 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -17.43 | -17.59 | -10.1 | -7.25 | -7.46 | -7.11 |
Capital Expenditures CapEx Growth | - | - | -0.32 | -0.03 | -0.19 | -0.12 |
Free Cash Flow Free Cash Flow Growth | -17.43 | -17.59 | -10.42 | -7.28 | -7.65 | -7.22 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Gross Margin | 0.72% | 0.61% | 0.83% | -11.99% | -3.55% | -4.16% |
Operating Margin | -21.40% | -25.32% | -281.38% | -476.97% | -366.74% | -934.33% |
Pretax Margin | -21.73% | -14.75% | -315.47% | -471.09% | -379.45% | -962.91% |
Profit Margin | -129.28% | -23.81% | -315.47% | -471.09% | -379.45% | -962.91% |
FCF Margin | -59.57% | -85.70% | -269.85% | -414.12% | -246.17% | -374.87% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
PS Ratio | 0.02 | 2.30 | - | - | - | - |